Topoisomeric Membrane-Active Peptides: A Review of the Last Two Decades.

Carrera-Aubesart, Adam et al.·Pharmaceutics·2023·
RPEP-067742023RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Topoisomeric peptides can maintain biological activity while resisting protease degradation.

Key Numbers

How They Did This

The study is a review that synthesizes findings from the last two decades on membrane-active peptides.

Why This Research Matters

Understanding how these peptides interact with cell membranes could lead to new therapeutic strategies in drug delivery and infection control. Their stability against degradation enhances their potential for clinical applications.

What This Study Doesn't Tell Us

As a review, it does not present original experimental data and may not cover all recent studies comprehensively.

Trust & Context

Original Title:
Topoisomeric Membrane-Active Peptides: A Review of the Last Two Decades.
Published In:
Pharmaceutics, 15(10) (2023)
Database ID:
RPEP-06774

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-06774·https://rethinkpeptides.com/research/RPEP-06774

APA

Carrera-Aubesart, Adam; Gallo, Maria; Defaus, Sira; Todorovski, Toni; Andreu, David. (2023). Topoisomeric Membrane-Active Peptides: A Review of the Last Two Decades.. Pharmaceutics, 15(10). https://doi.org/10.3390/pharmaceutics15102451

MLA

Carrera-Aubesart, Adam, et al. "Topoisomeric Membrane-Active Peptides: A Review of the Last Two Decades.." Pharmaceutics, 2023. https://doi.org/10.3390/pharmaceutics15102451

RethinkPeptides

RethinkPeptides Research Database. "Topoisomeric Membrane-Active Peptides: A Review of the Last ..." RPEP-06774. Retrieved from https://rethinkpeptides.com/research/carrera-aubesart-2023-topoisomeric-membraneactive-peptides-a

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.